You are here

CDC Releases New Infant Mortality Data

October 15, 2008 -- The United States ranked 29th in the world in infant mortality in 2004, compared to 27th in 2000, 23rd in 1990 and 12th in 1960, according to a new report from CDC's a href="">National Center for Health Statistics.

The U.S. infant mortality rate was 6.78 infant deaths per 1,000 live births in 2004, the latest year that data are available for all countries. Infant mortality rates were generally lowest (below 3.5 per 1,000) in selected Scandinavian (Sweden, Norway, Finland) and East Asian (Japan, Hong Kong, Singapore) countries. Twenty-two countries had infant mortality rates below 5.0 in 2004. The findings are published in a new data brief "Recent Trends in Infant Mortality in the United States." The data come from the Linked Birth/Infant Death Data Set and Preliminary Mortality Data File, collected through the National Vital Statistics System.

The report shows the U.S. infant mortality rate did not decline from 2000 to 2005. However, preliminary data for 2006 show a significant 2 percent decline between 2005 and 2006. Other findings include:

  • The current U.S. infant mortality rate is about 50 percent higher than the national goal of 4.5 infant deaths per 1,000 births.
  • The infant mortality rate for non-Hispanic black women was 2.4 times the rate for non-Hispanic white women. In 2005, the infant mortality rate for non-Hispanic black women was 13.63 infant deaths per 1,000 live births, compared to a rate of 5.76 for non-Hispanic white women. Rates were also higher for Puerto Rican and American Indian women, 8.30 and 8.06 respectively.
  • Increases in preterm birth and preterm-related infant mortality account for much of the lack of decline in the United States' infant mortality rate from 2000 to 2005.
The full report is available at

Source: Centers for Disease Control and Prevention

Recent Headlines

Findings from ISCHEMIA trial may mean fewer stents and bypass operations for those with stable disease
Donors hope to vaccinate 450 million children each year
New Novartis drug cuts rate of crises by 45% relative to placebo
FDA says new Pentax design is easier to clean
Myovant’s drug would offer a new oral, once-daily treatment option
More research is needed to confirm the finding
Study shows "complex genetic risk architecture"
Study says yes, interventions cuts need for meds
Review of 18 studies finds that medium doses have the strongest effects